Cancer
Plexxikon Announces Publication of Key Data Demonstrating Possible Personalized Medicine for a Variety of Cancers
Published in Cancer Weekly, March 4th, 2008
Plexxikon Inc. announced the publication of data from studies of Plexxikon's targeted cancer compound published in The Proceedings of the National Academy of Sciences by a team of scientists from Plexxikon and the Wistar Institute. Plexxikon's novel anti-cancer compound selectively destroys tumor cells which contain the B-Raf(V600E) cancer-causing mutation, a defect present in most melanomas and thyroid tumors and a large number of colorectal and other cancers. Patients with the BRAF(V600E) gene may have particularly aggressive tumors often resulting in much poorer survival outcomes.
Using its proprietary Scaffold-Based Drug Discovery(TM) platform, Plexxikon has...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2008-03-04)
More Articles from Cancer Weekly
- Cancer Vaccines
Researchers unveil landscape of human-pathogen protein interactions - Cancer Vaccines
Vaccine/antibody therapy effective, milder side effects in melanoma and ovarian cancer - Breast Cancer
Abviva Announces Patent Issuance for Core Technology Used in Mammastatin Serum Assay Diagnostic Test for Breast Cancer - Cancer Gene Therapy
New cancer gene therapy data have been reported by scientists at Rockefeller University - Cancer Gene Therapy
Research from Umea University provides new data on cancer gene therapy - Cancer Gene Therapy
Scientists at Soochow University release new data on cancer gene therapy - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
